Prediction of adjuvant chemotherapy benefit in endocrine responsive, early breast cancer using multigene assays
Author:
Publisher
Elsevier BV
Subject
General Medicine,Surgery
Reference37 articles.
1. International web-based consultation on priorities for translational breast cancer research;Dowsett;Breast Cancer Res,2007
2. Gene expression profiling of breast cancer: a new tumor marker;van't Veer;J Clin Oncol,2005
3. Gene-expression signatures in breast cancer;Sotiriou;N Engl J Med,2009
4. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer;Paik;N Engl J Med,2004
5. A population-based study of tumor gene expression and risk of breast cancer death among lymph node-negative patients;Habel;Breast Cancer Research,2006
Cited by 90 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Optimizer’s dilemma: optimization strongly influences model selection in transcriptomic prediction;Bioinformatics Advances;2024-01-01
2. Survival Benefit of Adjuvant Chemotherapy in Node-Positive Breast Cancer With a 21-Gene Recurrence Score of 14 to 25: A Real-World Study Based on the Inverse Probability of Treatment Weighting Method;Clinical Breast Cancer;2023-10
3. Determinants of response to CDK4/6 inhibitors in the real-world setting;npj Precision Oncology;2023-09-13
4. Biomarkers in Breast Cancer: An Old Story with a New End;Genes;2023-06-28
5. Optimizer’s dilemma: optimization strongly influences model selection in transcriptomic prediction;2023-06-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3